Takeda pushes back as group seeks to stop $62bn Shire deal
Bloomberg Takeda Pharmaceutical Co. Chief Executive Officer Christophe Weber pushed back against dissident shareholders seeking to stop the Japanese drugmaker’s acquisition of Shire Plc, saying he won’t release minutes of boardroom discussions. A group including members of Takeda’s founding family opposes the planned $62 billion acquisition of the UK-listed biotech firm, which would rank as the biggest overseas takeover by ...
Read More »